表紙：着床前診断（PGD）の世界市場：タイプ別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年）

市場調査レポート

商品コード

1085731

着床前診断（PGD）の世界市場：タイプ別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年）

Preimplantation Genetic Diagnosis Market, By Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月08日 | 発行: Coherent Market Insights

| ページ情報: 英文 188 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 701,325円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,950円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,558,500円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.85円

全表示
概要
目次

概要

サンプル依頼リストに入れる

着床前診断（PGD）の世界市場において、予測期間中の成長を阻害する主な要因は、移植用胚が利用できないことです。

当レポートでは、世界の着床前診断（PGD）市場について調査分析し、市場促進要因と抑制要因、市場機会、COVID-19の影響、タイプ・エンドユーザー・地域別の市場分析、競合情勢などを提供しています。

Preimplantation genetic diagnosis (PGD) is the genetic profiling of the pre implantable embryos and oocytes before their implantation. The preimplantation genetic diagnosis is similar to that of the parental diagnosis in case of screening for a particular genetic disease. The PGD is advantageous in a way that helps to avoid selective pregnancy termination by the development and growth of the healthy fetus. PGD serves as an addendum to assisted reproductive technology. The preimplantation genetic diagnosis is required in vitro fertilization, in order to obtain oocytes from the embryos for the genetic evaluation of the diseased or disease-free conditions. In simpler terms, the preimplantation genetic diagnosis is a technique that is used to identify embryos at risk.

Restraints of the Global Preimplantation Genetic Diagnosis Market

Major factors hampering the growth of the preimplantation genetic diagnosis market during the forecast period constitutes of non-availability of embryos for transfer.

Key features of the study:

This report provides in-depth analysis of the global preimplantation genetic diagnosis market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global preimplantation genetic diagnosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Amgen, Quest Diagnostics, Genentech Inc., Vertex, PerkinElmer, Inc., F. Hoffman-La-Roche Ltd, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Illumina, Inc., Natera Inc., CooperGenomics Inc., Reproductive Genetics Institute, Inc., Genea Ltd., Invitae Corporation, and CombiMatrix Corporation.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Preimplantation Genetic Diagnosis Market, By Type:
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
Global Preimplantation Genetic Diagnosis Market, By End User:
- Diagnostic Laboratories
- Hospitals
- Clinics
Global Preimplantation Genetic Diagnosis Market, By Geography:
- North America
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country:
- U.S.
- Canada
- Europe
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
By Type
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others (for disability, adult onset disease)
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
By Country/Region:
- Central Africa
- South Africa
- North Africa
Company Profiles
- Amgen Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
- Quest Diagnostics
- Vertex
- PerkinElmer, Inc.
- F. Hoffman-La-Roche Ltd
- Thermo Fisher Scientific, Inc.
- Laboratory Corporation of America Holdings
- Abbott Laboratories
- Illumina, Inc.
- Natera Inc.
- CooperGenomics Inc.
- Reproductive Genetics Institute, Inc.
- Genea Ltd.
- Invitae Corporation
- CombiMatrix Corporation

"" marked represents similar segmentation in other categories in the respective section.*

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis

4. Global Preimplantation Genetic Diagnosis Market, By Type, 2017 - 2028 (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Chromosomal Abnormalities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
Aneuploidy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
X-linked diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
Single gene disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
HLA Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
Gender Selection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
Others (for disability, adult onset disease)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends

5. Global Preimplantation Genetic Diagnosis Market, By End User, 2017 - 2028 (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Preimplantation Genetic Diagnosis Market, By Regions, 2017 - 2028 (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Amgen Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Quest Diagnostics
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vertex
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- PerkinElmer, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffman-La-Roche Ltd
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Laboratory Corporation of America Holdings
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Illumina, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Natera Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CooperGenomics Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Reproductive Genetics Institute, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Genea Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Invitae Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CombiMatrix Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

8. Section

References
Research Methodology
About us and Sales Contact

着床前診断（PGD）の世界市場：タイプ別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年）

Preimplantation Genetic Diagnosis Market, By Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場の範囲

第3章市場力学・規制・動向分析

第4章世界の着床前診断（PGD）市場：タイプ別（2017年～2028年）

第5章世界の着床前診断（PGD）市場：エンドユーザー別（2017年～2028年）

第6章世界の着床前診断（PGD）市場：地域別（2017年～2028年）

第7章競合情勢

第8章セクション

Restraints of the Global Preimplantation Genetic Diagnosis Market

Key features of the study:

Detailed Segmentation

"" marked represents similar segmentation in other categories in the respective section.*

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preimplantation Genetic Diagnosis Market, By Type, 2017 - 2028 (US$ Mn)

5. Global Preimplantation Genetic Diagnosis Market, By End User, 2017 - 2028 (US$ Mn)

6. Global Preimplantation Genetic Diagnosis Market, By Regions, 2017 - 2028 (US$ Mn)

7. Competitive Landscape

8. Section

着床前診断（PGD）の世界市場：タイプ別、エンドユーザー別、地域別 - 規模、シェア、展望、機会分析（2022年～2028年）

Preimplantation Genetic Diagnosis Market, By Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場の範囲

第3章 市場力学・規制・動向分析

第4章 世界の着床前診断（PGD）市場：タイプ別（2017年～2028年）

第5章 世界の着床前診断（PGD）市場：エンドユーザー別（2017年～2028年）

第6章 世界の着床前診断（PGD）市場：地域別（2017年～2028年）

第7章 競合情勢

第8章 セクション

Restraints of the Global Preimplantation Genetic Diagnosis Market

Key features of the study:

Detailed Segmentation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Preimplantation Genetic Diagnosis Market, By Type, 2017 - 2028 (US$ Mn)

5. Global Preimplantation Genetic Diagnosis Market, By End User, 2017 - 2028 (US$ Mn)

6. Global Preimplantation Genetic Diagnosis Market, By Regions, 2017 - 2028 (US$ Mn)

7. Competitive Landscape

8. Section

第1章調査目的・前提条件

第2章市場の範囲

第3章市場力学・規制・動向分析

第4章世界の着床前診断（PGD）市場：タイプ別（2017年～2028年）

第5章世界の着床前診断（PGD）市場：エンドユーザー別（2017年～2028年）

第6章世界の着床前診断（PGD）市場：地域別（2017年～2028年）

第7章競合情勢

第8章セクション

"" marked represents similar segmentation in other categories in the respective section.*